Watertown, MA, United States of America

William C Shakespeare

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William C Shakespeare. Retrieved from https://idiyas.com/inventor/william-c-shakespeare-9xyqj1oj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William C. Shakespeare

Introduction: William C. Shakespeare is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of chemistry, particularly in the development of non-peptide peptidomimetics. His work has implications for therapeutic methods and the understanding of peptide interactions with G-protein-linked receptors.

Latest Patents: William C. Shakespeare holds a patent for "Non-peptide peptidomimetics." This patent describes compounds that are crossreactive with peptides, which bind to G-protein-linked receptors. The compounds have a general structure that allows for various preparative and therapeutic methods.

Career Highlights: Shakespeare is affiliated with the University of Pennsylvania, where he has been involved in groundbreaking research. His work has contributed to advancements in medicinal chemistry and the development of new therapeutic agents.

Collaborations: Throughout his career, William C. Shakespeare has collaborated with esteemed colleagues such as Ralph F. Hirschmann and John Hynes, Jr. These collaborations have further enriched his research and innovation in the field.

Conclusion: William C. Shakespeare's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence therapeutic methods and the understanding of peptide interactions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…